Bifogade filer
Observe_Medical_ASA_Redelivery_of_lent_shares_to_person_closely_associated_with_primary_insider_and_mandatory_notification_of_trade
Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-08-06 08:00:18
Oslo, 6 August 2024
Reference is made to the stock exchange announcement by Observe Medical ASA
("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 July 2024 (the
"Announcement"), regarding share lending by Ingerø Reiten Investment Company AS
in connection with tranche 2 of the private placement of new shares in the
Company (the "Private Placement").
The share capital increase pertaining to tranche 2 of the Private Placement has
now been registered, as announced by the Company yesterday, and the shares that
were lent by Ingerø Reiten Investment Company AS have been redelivered.
Following the return of the lent shares and the allocation of offer shares in
tranche 2 of the Private Placement, Ingerø Reiten Investment Company AS holds
43,009,437 shares in the Company (representing approximately 17,51% of the
issued share capital and votes). Consequently, Ingerø Reiten Investment Company
AS' shareholding has crossed the 15% threshold pursuant to Section 4-2 (1)
cf.(3) of the Norwegian Securities Trading Act.
For more information about the redelivery of the lent shares, see the attached
form.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and sections 4-2 and 5-12 of the Norwegian
Securities Trading Act.
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical:
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.